pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3123 |
Genomic Coordinates | chr1: 241132272 - 241132346 |
Description | Homo sapiens miR-3123 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3123 | ||||||||||||||
Sequence | 49| CAGAGAAUUGUUUAAUC |65 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Illumina | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NRAS | ||||||||||||||||||||
Synonyms | ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6 | ||||||||||||||||||||
Description | NRAS proto-oncogene, GTPase | ||||||||||||||||||||
Transcript | NM_002524 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NRAS | |||||||||||||||||||||
3'UTR of NRAS (miRNA target sites are highlighted) |
>NRAS|NM_002524|3'UTR 1 CAAGATACTTTTAAAGTTTTGTCAGAAAAGAGCCACTTTCAAGCTGCACTGACACCCTGGTCCTGACTTCCCTGGAGGAG 81 AAGTATTCCTGTTGCTGTCTTCAGTCTCACAGAGAAGCTCCTGCTACTTCCCCAGCTCTCAGTAGTTTAGTACAATAATC 161 TCTATTTGAGAAGTTCTCAGAATAACTACCTCCTCACTTGGCTGTCTGACCAGAGAATGCACCTCTTGTTACTCCCTGTT 241 ATTTTTCTGCCCTGGGTTCTTCCACAGCACAAACACACCTCTGCCACCCCAGGTTTTTCATCTGAAAAGCAGTTCATGTC 321 TGAAACAGAGAACCAAACCGCAAACGTGAAATTCTATTGAAAACAGTGTCTTGAGCTCTAAAGTAGCAACTGCTGGTGAT 401 TTTTTTTTTCTTTTTACTGTTGAACTTAGAACTATGCTAATTTTTGGAGAAATGTCATAAATTACTGTTTTGCCAAGAAT 481 ATAGTTATTATTGCTGTTTGGTTTGTTTATAATGTTATCGGCTCTATTCTCTAAACTGGCATCTGCTCTAGATTCATAAA 561 TACAAAAATGAATACTGAATTTTGAGTCTATCCTAGTCTTCACAACTTTGACGTAATTAAATCCAACTTTCACAGTGAAG 641 TGCCTTTTTCCTAGAAGTGGTTTGTAGACTTCCTTTATAATATTTCAGTGGAATAGATGTCTCAAAAATCCTTATGCATG 721 AAATGAATGTCTGAGATACGTCTGTGACTTATCTACCATTGAAGGAAAGCTATATCTATTTGAGAGCAGATGCCATTTTG 801 TACATGTATGAAATTGGTTTTCCAGAGGCCTGTTTTGGGGCTTTCCCAGGAGAAAGATGAAACTGAAAGCACATGAATAA 881 TTTCACTTAATAATTTTTACCTAATCTCCACTTTTTTCATAGGTTACTACCTATACAATGTATGTAATTTGTTTCCCCTA 961 GCTTACTGATAAACCTAATATTCAATGAACTTCCATTTGTATTCAAATTTGTGTCATACCAGAAAGCTCTACATTTGCAG 1041 ATGTTCAAATATTGTAAAACTTTGGTGCATTGTTATTTAATAGCTGTGATCAGTGATTTTCAAACCTCAAATATAGTATA 1121 TTAACAAATTACATTTTCACTGTATATCATGGTATCTTAATGATGTATATAATTGCCTTCAATCCCCTTCTCACCCCACC 1201 CTCTACAGCTTCCCCCACAGCAATAGGGGCTTGATTATTTCAGTTGAGTAAAGCATGGTGCTAATGGACCAGGGTCACAG 1281 TTTCAAAACTTGAACAATCCAGTTAGCATCACAGAGAAAGAAATTCTTCTGCATTTGCTCATTGCACCAGTAACTCCAGC 1361 TAGTAATTTTGCTAGGTAGCTGCAGTTAGCCCTGCAAGGAAAGAAGAGGTCAGTTAGCACAAACCCTTTACCATGACTGG 1441 AAAACTCAGTATCACGTATTTAAACATTTTTTTTTCTTTTAGCCATGTAGAAACTCTAAATTAAGCCAATATTCTCATTT 1521 GAGAATGAGGATGTCTCAGCTGAGAAACGTTTTAAATTCTCTTTATTCATAATGTTCTTTGAAGGGTTTAAAACAAGATG 1601 TTGATAAATCTAAGCTGATGAGTTTGCTCAAAACAGGAAGTTGAAATTGTTGAGACAGGAATGGAAAATATAATTAATTG 1681 ATACCTATGAGGATTTGGAGGCTTGGCATTTTAATTTGCAGATAATACCCTGGTAATTCTCATGAAAAATAGACTTGGAT 1761 AACTTTTGATAAAAGACTAATTCCAAAATGGCCACTTTGTTCCTGTCTTTAATATCTAAATACTTACTGAGGTCCTCCAT 1841 CTTCTATATTATGAATTTTCATTTATTAAGCAAATGTCATATTACCTTGAAATTCAGAAGAGAAGAAACATATACTGTGT 1921 CCAGAGTATAATGAACCTGCAGAGTTGTGCTTCTTACTGCTAATTCTGGGAGCTTTCACAGTACTGTCATCATTTGTAAA 2001 TGGAAATTCTGCTTTTCTGTTTCTGCTCCTTCTGGAGCAGTGCTACTCTGTAATTTTCCTGAGGCTTATCACCTCAGTCA 2081 TTTCTTTTTTAAATGTCTGTGACTGGCAGTGATTCTTTTTCTTAAAAATCTATTAAATTTGATGTCAAATTAGGGAGAAA 2161 GATAGTTACTCATCTTGGGCTCTTGTGCCAATAGCCCTTGTATGTATGTACTTAGAGTTTTCCAAGTATGTTCTAAGCAC 2241 AGAAGTTTCTAAATGGGGCCAAAATTCAGACTTGAGTATGTTCTTTGAATACCTTAAGAAGTTACAATTAGCCGGGCATG 2321 GTGGCCCGTGCCTGTAGTCCCAGCTACTTGAGAGGCTGAGGCAGGAGAATCACTTCAACCCAGGAGGTGGAGGTTACAGT 2401 GAGCAGAGATCGTGCCACTGCACTCCAGCCTGGGTGACAAGAGAGACTTGTCTCCAAAAAAAAAGTTACACCTAGGTGTG 2481 AATTTTGGCACAAAGGAGTGACAAACTTATAGTTAAAAGCTGAATAACTTCAGTGTGGTATAAAACGTGGTTTTTAGGCT 2561 ATGTTTGTGATTGCTGAAAAGAATTCTAGTTTACCTCAAAATCCTTCTCTTTCCCCAAATTAAGTGCCTGGCCAGCTGTC 2641 ATAAATTACATATTCCTTTTGGTTTTTTTAAAGGTTACATGTTCAAGAGTGAAAATAAGATGTTCTGTCTGAAGGCTACC 2721 ATGCCGGATCTGTAAATGAACCTGTTAAATGCTGTATTTGCTCCAACGGCTTACTATAGAATGTTACTTAATACAATATC 2801 ATACTTATTACAATTTTTACTATAGGAGTGTAATAGGTAAAATTAATCTCTATTTTAGTGGGCCCATGTTTAGTCTTTCA 2881 CCATCCTTTAAACTGCTGTGAATTTTTTTGTCATGACTTGAAAGCAAGGATAGAGAAACACTTTAGAGATATGTGGGGTT 2961 TTTTTACCATTCCAGAGCTTGTGAGCATAATCATATTTGCTTTATATTTATAGTCATGAACTCCTAAGTTGGCAGCTACA 3041 ACCAAGAACCAAAAAATGGTGCGTTCTGCTTCTTGTAATTCATCTCTGCTAATAAATTATAAGAAGCAAGGAAAATTAGG 3121 GAAAATATTTTATTTGGATGGTTTCTATAAACAAGGGACTATAATTCTTGTACATTATTTTTCATCTTTGCTGTTTCTTT 3201 GAGCAGTCTAATGTGCCACACAATTATCTAAGGTATTTGTTTTCTATAAGAATTGTTTTAAAAGTATTCTTGTTACCAGA 3281 GTAGTTGTATTATATTTCAAAACGTAAGATGATTTTTAAAAGCCTGAGTACTGACCTAAGATGGAATTGTATGAACTCTG 3361 CTCTGGAGGGAGGGGAGGATGTCCGTGGAAGTTGTAAGACTTTTATTTTTTTGTGCCATCAAATATAGGTAAAAATAATT 3441 GTGCAATTCTGCTGTTTAAACAGGAACTATTGGCCTCCTTGGCCCTAAATGGAAGGGCCGATATTTTAAGTTGATTATTT 3521 TATTGTAAATTAATCCAACCTAGTTCTTTTTAATTTGGTTGAATGTTTTTTCTTGTTAAATGATGTTTAAAAAATAAAAA 3601 CTGGAAGTTCTTGGCTTAGTCATAATTCTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000369535.4 | 3UTR | UUAUCGGCUCUAUUCUCUAAACUGGCAUCUGCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
113 hsa-miR-3123 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT058369 | TBCEL | tubulin folding cofactor E like | 2 | 4 | ||||||||
MIRT059816 | EFNA1 | ephrin A1 | 2 | 2 | ||||||||
MIRT066850 | TMEM19 | transmembrane protein 19 | 2 | 2 | ||||||||
MIRT071503 | CALM1 | calmodulin 1 | 2 | 6 | ||||||||
MIRT073758 | NUBP1 | nucleotide binding protein 1 | 2 | 2 | ||||||||
MIRT074324 | TNRC6A | trinucleotide repeat containing 6A | 2 | 10 | ||||||||
MIRT094805 | LMNB1 | lamin B1 | 2 | 2 | ||||||||
MIRT099173 | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 2 | 2 | ||||||||
MIRT099545 | ID4 | inhibitor of DNA binding 4, HLH protein | 2 | 2 | ||||||||
MIRT122643 | E2F3 | E2F transcription factor 3 | 2 | 2 | ||||||||
MIRT180918 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | 2 | 8 | ||||||||
MIRT192844 | BLOC1S6 | biogenesis of lysosomal organelles complex 1 subunit 6 | 2 | 2 | ||||||||
MIRT224984 | BAG4 | BCL2 associated athanogene 4 | 2 | 2 | ||||||||
MIRT246065 | NRAS | NRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT357085 | PRRC1 | proline rich coiled-coil 1 | 2 | 2 | ||||||||
MIRT378170 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 2 | ||||||||
MIRT441636 | KDM5A | lysine demethylase 5A | 2 | 2 | ||||||||
MIRT441802 | BCAS1 | breast carcinoma amplified sequence 1 | 2 | 2 | ||||||||
MIRT443019 | C21orf91 | chromosome 21 open reading frame 91 | 2 | 2 | ||||||||
MIRT443445 | SERPINB4 | serpin family B member 4 | 2 | 2 | ||||||||
MIRT443661 | SERPINB3 | serpin family B member 3 | 2 | 2 | ||||||||
MIRT443776 | STS | steroid sulfatase | 2 | 2 | ||||||||
MIRT444663 | TSPAN14 | tetraspanin 14 | 2 | 2 | ||||||||
MIRT444924 | KIAA1522 | KIAA1522 | 2 | 2 | ||||||||
MIRT445378 | FOXO1 | forkhead box O1 | 2 | 2 | ||||||||
MIRT447920 | PAIP2B | poly(A) binding protein interacting protein 2B | 2 | 2 | ||||||||
MIRT449202 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT449713 | TSPYL1 | TSPY like 1 | 2 | 2 | ||||||||
MIRT450403 | TMEM47 | transmembrane protein 47 | 2 | 2 | ||||||||
MIRT450787 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT451381 | C19orf43 | telomerase RNA component interacting RNase | 2 | 2 | ||||||||
MIRT452507 | WDR1 | WD repeat domain 1 | 2 | 2 | ||||||||
MIRT453264 | PARP11 | poly(ADP-ribose) polymerase family member 11 | 2 | 2 | ||||||||
MIRT454642 | FAM83H | family with sequence similarity 83 member H | 2 | 2 | ||||||||
MIRT455513 | C6orf106 | chromosome 6 open reading frame 106 | 2 | 2 | ||||||||
MIRT456709 | LDB1 | LIM domain binding 1 | 2 | 2 | ||||||||
MIRT457231 | AP3D1 | adaptor related protein complex 3 delta 1 subunit | 2 | 2 | ||||||||
MIRT459235 | MRPS21 | mitochondrial ribosomal protein S21 | 2 | 2 | ||||||||
MIRT460553 | IFNAR1 | interferon alpha and beta receptor subunit 1 | 2 | 4 | ||||||||
MIRT461424 | CTSL2 | cathepsin V | 2 | 3 | ||||||||
MIRT462869 | CYP51A1 | cytochrome P450 family 51 subfamily A member 1 | 2 | 2 | ||||||||
MIRT467178 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | 2 | 2 | ||||||||
MIRT469233 | RHOBTB3 | Rho related BTB domain containing 3 | 2 | 2 | ||||||||
MIRT474125 | LIPC | lipase C, hepatic type | 2 | 2 | ||||||||
MIRT475509 | HSP90B1 | heat shock protein 90 beta family member 1 | 2 | 4 | ||||||||
MIRT478134 | DHX36 | DEAH-box helicase 36 | 2 | 2 | ||||||||
MIRT481326 | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | 2 | 2 | ||||||||
MIRT482003 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT482230 | AHCYL2 | adenosylhomocysteinase like 2 | 2 | 2 | ||||||||
MIRT483436 | RHOXF2B | Rhox homeobox family member 2B | 2 | 2 | ||||||||
MIRT483824 | ZC3H12B | zinc finger CCCH-type containing 12B | 2 | 2 | ||||||||
MIRT492051 | TNFSF9 | TNF superfamily member 9 | 2 | 2 | ||||||||
MIRT494114 | DLX6 | distal-less homeobox 6 | 2 | 2 | ||||||||
MIRT498882 | ZNF12 | zinc finger protein 12 | 2 | 10 | ||||||||
MIRT499674 | NPHP3 | nephrocystin 3 | 2 | 2 | ||||||||
MIRT506932 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 6 | ||||||||
MIRT509461 | ZNF587 | zinc finger protein 587 | 2 | 6 | ||||||||
MIRT510048 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 4 | ||||||||
MIRT514807 | NWD1 | NACHT and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT515217 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT515486 | INCENP | inner centromere protein | 2 | 4 | ||||||||
MIRT517765 | ZNF366 | zinc finger protein 366 | 2 | 4 | ||||||||
MIRT518216 | TRMT10B | tRNA methyltransferase 10B | 2 | 2 | ||||||||
MIRT519602 | ZNF805 | zinc finger protein 805 | 2 | 2 | ||||||||
MIRT523570 | GGCX | gamma-glutamyl carboxylase | 2 | 4 | ||||||||
MIRT525795 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT533055 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT534218 | SLC37A3 | solute carrier family 37 member 3 | 2 | 4 | ||||||||
MIRT535633 | NR2E1 | nuclear receptor subfamily 2 group E member 1 | 2 | 2 | ||||||||
MIRT535863 | MRPL17 | mitochondrial ribosomal protein L17 | 2 | 2 | ||||||||
MIRT536344 | LEFTY1 | left-right determination factor 1 | 2 | 2 | ||||||||
MIRT537923 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT543114 | SKA2 | spindle and kinetochore associated complex subunit 2 | 2 | 2 | ||||||||
MIRT544717 | ZNF529 | zinc finger protein 529 | 2 | 2 | ||||||||
MIRT544847 | BASP1 | brain abundant membrane attached signal protein 1 | 2 | 4 | ||||||||
MIRT545536 | ARF3 | ADP ribosylation factor 3 | 2 | 2 | ||||||||
MIRT547124 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT548070 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT548446 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 2 | ||||||||
MIRT548626 | DAZAP1 | DAZ associated protein 1 | 2 | 4 | ||||||||
MIRT550259 | FAM120AOS | family with sequence similarity 120A opposite strand | 2 | 2 | ||||||||
MIRT551940 | AKAP8 | A-kinase anchoring protein 8 | 2 | 4 | ||||||||
MIRT552511 | ZIK1 | zinc finger protein interacting with K protein 1 | 2 | 4 | ||||||||
MIRT554015 | SPIRE1 | spire type actin nucleation factor 1 | 2 | 2 | ||||||||
MIRT556647 | KPNA2 | karyopherin subunit alpha 2 | 2 | 4 | ||||||||
MIRT559744 | ACOX1 | acyl-CoA oxidase 1 | 2 | 2 | ||||||||
MIRT560393 | TMEM254 | transmembrane protein 254 | 2 | 2 | ||||||||
MIRT562234 | HMGB2 | high mobility group box 2 | 2 | 2 | ||||||||
MIRT563325 | ORC4 | origin recognition complex subunit 4 | 2 | 2 | ||||||||
MIRT563697 | RPS26 | ribosomal protein S26 | 2 | 2 | ||||||||
MIRT565066 | USP25 | ubiquitin specific peptidase 25 | 2 | 2 | ||||||||
MIRT565349 | TMED2 | transmembrane p24 trafficking protein 2 | 2 | 2 | ||||||||
MIRT565624 | SLC31A1 | solute carrier family 31 member 1 | 2 | 2 | ||||||||
MIRT566379 | PNISR | PNN interacting serine and arginine rich protein | 2 | 2 | ||||||||
MIRT567575 | FEM1C | fem-1 homolog C | 2 | 2 | ||||||||
MIRT569383 | DDX20 | DEAD-box helicase 20 | 2 | 2 | ||||||||
MIRT570037 | FAM228A | family with sequence similarity 228 member A | 2 | 2 | ||||||||
MIRT573269 | DCAF10 | DDB1 and CUL4 associated factor 10 | 2 | 2 | ||||||||
MIRT573912 | PARP1 | poly(ADP-ribose) polymerase 1 | 2 | 2 | ||||||||
MIRT620034 | ST6GALNAC3 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | 2 | 2 | ||||||||
MIRT635606 | ZWILCH | zwilch kinetochore protein | 2 | 2 | ||||||||
MIRT644413 | FRMD6 | FERM domain containing 6 | 2 | 2 | ||||||||
MIRT652528 | TM9SF4 | transmembrane 9 superfamily member 4 | 2 | 2 | ||||||||
MIRT656238 | MFSD6 | major facilitator superfamily domain containing 6 | 2 | 2 | ||||||||
MIRT661373 | DYRK4 | dual specificity tyrosine phosphorylation regulated kinase 4 | 2 | 2 | ||||||||
MIRT662530 | PNPLA4 | patatin like phospholipase domain containing 4 | 2 | 2 | ||||||||
MIRT675551 | MALL | mal, T-cell differentiation protein like | 2 | 2 | ||||||||
MIRT693650 | ACBD7 | acyl-CoA binding domain containing 7 | 2 | 2 | ||||||||
MIRT696348 | SLC35D2 | solute carrier family 35 member D2 | 2 | 2 | ||||||||
MIRT705815 | AKNA | AT-hook transcription factor | 2 | 2 | ||||||||
MIRT707632 | TARDBP | TAR DNA binding protein | 2 | 2 | ||||||||
MIRT717902 | COPS8 | COP9 signalosome subunit 8 | 2 | 2 | ||||||||
MIRT723626 | SOBP | sine oculis binding protein homolog | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|